Bill Nygren
Oakmark Select Fund
Bill Nygren HCA Healthcare, Inc stake
total: 60
Oakmark Select Fund HCA trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 2
- Reduced:
- 3
- Held since:
- 2020 Q3
- Held for:
- 12 quarters
- Latest activity:
- 2023 Q3
According to 2026 Q1 report, Bill Nygren doesn't hold any HCA Healthcare, Inc (HCA) shares. To date, the estimated cost basis is nearly $129.1 for "buy" trades and estimated average "sell" price is $287.92. Oakmark Select Fund first purchased HCA in 2020 Q3, initially acquiring 764,346 shares. Since the initial investment in HCA Healthcare, Inc (HCA), Oakmark Select Fund has made 6 more transactions.
When did Bill Nygren sell HCA Healthcare, Inc (HCA)?
Bill Nygren sold off the entire HCA Healthcare, Inc (HCA) position in 2023 Q3.
When did Bill Nygren buy HCA Healthcare, Inc (HCA)?
Bill Nygren first invested in HCA Healthcare, Inc (HCA) in 2020 Q3 at the reported quarter-end price of $124.68 per share.
What's the cost basis of Oakmark Select Fund's HCA stake?
The estimated cost basis for HCA Healthcare, Inc (HCA) stake is around $129.10 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $129.10
- Weighted AVG sell price:
- $287.92
Bill Nygren's historical trades in HCA Healthcare, Inc
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q3
|
0.00%
|
0
|
$303.48
|
|
-100% (-552,746)
|
-3.13%
|
|
2023 Q1
|
3.05%
|
552,746
|
$263.68
|
$145,748,065
|
-27.01% (-204,500)
|
-1.26%
|
|
2022 Q4
|
4.24%
|
757,246
|
$239.96
|
$181,708,750
|
-2.32% (-18,000)
|
-0.1%
|
|
2022 Q3
|
3.36%
|
775,246
|
$183.79
|
$142,482,462
|
+4.73% (+35,000)
|
+0.15%
|
|
2022 Q2
|
2.79%
|
740,246
|
$168.06
|
$124,405,743
|
+5.34% (+37,500)
|
+0.14%
|
|
2021 Q3
|
3.14%
|
702,746
|
$242.72
|
$170,570,509
|
-8.06% (-61,600)
|
-0.29%
|
|
2020 Q3
|
2.80%
|
$124.68
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.